Research Personnels

Dr Fikri

Dr. Fathinul Fikri Ahmad Saad

Tel:   603 89471646
Fax:  603 89472585
email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Dr. Zanariah Hussein (Endocrinologist Putrajaya Hosp.)

AP Dr Cheah Yoke Kqueen (Bioinformatics & genetic)

AP Dr Shiran Mohd Sidek (Pathology)

Dr. Mohd Zaid Fatah (Biostatistics & Epidemiology)

Research Officer

Cik Salasiah Mustafa

Master Student

Dr. Masiyati Abdul Jamil

Research Overview

The Oncology  Research laboratory is focused on the development and use of molecular imaging techniques, particularly positron emission tomography (PET), for in vivo functional imaging of tumours.  Employing a fast cutting edge PET/CT technology scanner, we non-invasively image changes in SUV  ( quantitative method) of different tumour biology in human subjects as a method of reserach in presurgical staging of tumour, treatment monitoring, localization of tumour recurrence, prediction of tumour aggressiveness and prognostication of patient survival. With positron-emitting tracers to visualise processes such as metabolism, proliferation, amino acid transport and hypoxia, we are able to assess important functional changes in tumours as they grow or respond to therapy. Further, we use PET probe to reveal how specific downstream signaling of tumour biology  could be indicated by the changes  shown by independent molecular markers for which phenomena may unfold novel discoveries in the methods of cancer detection and assessment of the treatment efficacy. Alongside PET, we employ ultrasound and high resolution quantitative  autoradiography study i.e mRNA  for preclinical and basic imaging research, with a focus on early clinical translational studies. In ultrasound experiments it is possible to non-invasively determine extent of tumour vascularisation and fluid balance to quantify effects of anti-cancer therapies that target angiogenesis in tumours. High resolution ex-vivo autoradiography further provides capability to determine functional properties of tumour subregions and assay responses at the level of individual cellular masses within a tumour.

Research Focus

Identification of specific molecular abnormalities in tumours, and defining their contribution to the cancer process and signaling , are leading to important changes in how we predict cancer aggressiveness while providing a much accurate presurgical staging and localisation of recurrent tumour for the purpose of tailoring to the treatment strategy. Such knowledge will allow more effective treatment adoption in the setting of the individual patient's genetic makeup and disease process. Our program therefore offers clinical and laboratory based projects that cover a range of research problems related to cancer development, progression of treatment, some with a definite clinical application and others that involve more basic questions of biological regulation. The broad program areas include pre-clinical molecular immunology and cellular biology , cancer imaging, epigenetic and genomic molecular biology.

Research Projects


Utility of the contrasted 18F-FDG PET/CT in the evaluation of  recurrent


Research Grant

Research Univ. Grant Scheme (RUGS)

Grant Amounts

RM 30 000

Research Outputs


F Fathinul, WFE Lau. An intense 18F- FDG pulmonary microfocus on PETwithout detectable abnormality on CT: A manifestation of an iatrogenic FDG pulmonary embolus. Biomed Imaging Interv J 2009;    6(4):e37(pubmed citation)

F Fathinul, WFE Lau . A subcentimetre single pulmonary nodule (SPN) ; Potentials of    FDG-PET interpretative pitfalls in patients with a known  extrapulmonary malignancy. Biomed Imaging Interv J 2009;    6(4):e34 (pubmed citation)

Fathinul F , Abdul Jalil Nordin. Imaging of the chronic  osteomyelitis; 18 F-FDG PET /CT as a  potential valuable adjunct  to MRI in characterisingthe brodie's abscess . Biomed Imaging Interv J 2010;    5(2):e26 (pubmed citation)

F Fathinul, WFE Lau.  Avid 18F-FDG uptake of pectoralis major muscle: an equivocal  sequela of strenuous physical exercise. Biomed Imaging Interv J 2009;   5(2):e7 (pubmed citation)

Fathinul Fikri AS, Abdul Jalil Nordin, Nuhafizah Mokhtarudin, Hemalata,W F Eddie Lau . 18[F] FDG-PET/CT is a useful molecular marker in evaluating thymoma aggressiveness. European Journal of Radiology Extra EJREX961 (pubmed citation)


F. Fathinul, A.J. Nordin, A.R. Noraini and H. Zanariah The value of a combined contrasted CT/[18F]FDG-PET in phaechromocytoma/paragangliomarecurrence: initial experience. Cancer Imaging (2010) 10, S47--S48 . International Cancer Imaging Society Meeting, Edinburg, Scotland (2010)

Zanariah H, Fathinul F, Nordin AJ. Usefulness of combined 18F-FDG PET/CT imaging in familial paraganglioma syndrome. - A tale of two siblings. Journal of Endocrinology & Metabolism. Proceedings of the 14th Asia Oceania Congress of Endocrinology, Kuala Lumpur, Malaysia. 2nd - 5th December 2010.

Zanariah H, Fathinul F, Nordin AJ. Initial experience with the use of combinedcontrasted CT/[18F]FDG-PET studies in localizing metastatic and recurrent phaechromocytoma/paraganglioma. Journal of Endocrinology & Metabolism.Proceedings of the 14th Asia Oceania Congress of Endocrinology, Kuala Lumpur, Malaysia. 2nd - 5th December 2010.

Sethu Thakachy Subha1,2, , Fathinul Fikri Ahmad Saad, Saraiza Abu Bakar, Muhamad Azrif , Abdul Jalil Nordin. The Clinical Outcome of  head and neck malignancy patients using integrated Positron Emission TomographyComputed Tomography  -  an initial experience.  The 14th Asean ORL Head andNeck Congress, May 2011, Sarawak

Abdul Jalil Nordin, Wan Himratul Azliza Wan Harun , Ahmad Zaid Fatah Azman, Ahmad Fazli Abdul Aziz, Fathinul Fikri Ahmad Saad, Zul Hilmi Yaakob ,Annuar Rapaie ,Wan Azman Wan Ahmad , Evaluating the status of hypoperfused myocardial segments during 99mTc-sestamibi resting myocardial perfusion imaging study using the new integrated imaging modality Positron Emission Emission Computedec Tomography (PET/CT). 18th Asean Asia Pacific Congress of Cardiology, May, 2011

F. Fathinul, A.J. Nordin, A.R. Noraini and H. Zanariah . superiority of a combined contrasted ct/[18f]fdg-pet in phaechromocytoma / paraganglioma(pcc/pgl)recurrence: initial experience". Annual Scientific Meeting, College of Radiology Malaysia 2011, April 2011

.F. Fathinul, A.J. Nordin, A.R. Noraini and H. Zanariah .Cardiac  paraganglioma in familial paraganglioma syndrome;   the value of 18f-fdg-pet/ct in evaluatingprevalence of a potentially aggressive disease. Annual Scientific Meeting,College of Radiology Malaysia 2011, April 2011


Fathinul Fikri AS, Abdul Jalil Nordin, Nuhafizah Mokhtarudin, Hemalata, W F Eddie Lau . 18[F] FDG-PET/CT is a useful molecular marker in evaluatingthymoma aggressiveness. Pameran Rekacipta Penyelidikan dan Inovasi (PRPi),UPM, 19-21 Julai 2011 (Bronze)

F. Fathinul, A.J. Nordin, A.R. Noraini and H. Zanariah . Cardiac  paraganglioma in familial paraganglioma syndrome;   the value of 18f-fdg-pet/ct in evaluating prevalence of a potentially aggressive disease. Scientific cancer research andexhibition (World Cancer Day) Main hall, Univ. Putra Malaysia.22nd-25th feb.2011 (Bronze)


Copyright © 2011 Pusat Pengimejan Diagnostik Nuklear, Universiti Putra Malaysia, 43400 UPM Serdang, Selangor, Malaysia | Tel : 603-8947 1644 | Fax : 603-8947 2775